Key Insights

Highlights

Success Rate

72% trial completion

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 62/100

Termination Rate

9.1%

5 terminated out of 55 trials

Success Rate

72.2%

-14.3% vs benchmark

Late-Stage Pipeline

7%

4 trials in Phase 3/4

Results Transparency

15%

2 of 13 completed with results

Key Signals

2 with results72% success

Data Visualizations

Phase Distribution

40Total
Not Applicable (35)
P 2 (1)
P 3 (1)
P 4 (3)

Trial Status

Recruiting13
Completed13
Unknown9
Active Not Recruiting6
Not Yet Recruiting6
Terminated5

Trial Success Rate

72.2%

Benchmark: 86.6%

Based on 13 completed trials

Clinical Trials (55)

Showing 20 of 20 trials
NCT07471308Active Not Recruiting

P-wave Duration and Local Potential as Predictors of AF Recurrence Following Pulmonary Vein Isolation

NCT06828939Not ApplicableRecruitingPrimary

Pulmonary Vein Isolation With the Single Shot Endoscopic Ultra-Compliant PFA Balloon for the Treatment of AF

NCT07694570Not Yet RecruitingPrimary

Feasibility Study: Continuous ECG and Blood Pressure Monitoring With the M2VS Sensor System

NCT06557876Not ApplicableRecruitingPrimary

The Effect of Pulse Field Ablation on Atrial Mechanics in Catheter Ablation of Paroxysmal Atrial Fibrillation

NCT07454317Not ApplicableRecruitingPrimary

Biofeedback Intervention for Paroxysmal Atrial Fibrillation

NCT06364215Not ApplicableTerminatedPrimary

Posterior Wall Substrate Modification Using Irreversible Electroporation for Paroxysmal Atrial Fibrillation

NCT07586176Not ApplicableActive Not RecruitingPrimary

3-Dimensional Mapping System: The PULSTAR II Study

NCT06172699CompletedPrimary

Assert-IQ Implantable Cardiac Monitor (ICM) Post Market Study

NCT07018596Not ApplicableRecruitingPrimary

NS-PFA Catheter Ablation of Paroxysmal Atrial Fibrillation With the Pulse Biosciences CellFX System

NCT06696170Not ApplicableRecruitingPrimary

CellFX® Nanosecond Pulsed Field Ablation (PFA) 360 Catheter Ablation System for Treatment of Atrial Fibrillation

NCT07541339Not ApplicableNot Yet RecruitingPrimary

Safety and Efficacy of Conscious Sedation Versus General Anesthesia in Pulsed-Field Ablation for Paroxysmal Atrial Fibrillation

NCT07324772Not ApplicableNot Yet Recruiting

PREACTIVE: Preconditioning Exercise Intervention to Improve Symptoms and Quality of Life in Comorbid Atrial Fibrillation and HFpEF

NCT06706518CompletedPrimary

Systematic Workflow for Pentaspline Pulsed-field Ablation Optimization

NCT07469579Not ApplicableNot Yet Recruiting

ALPs Single ChambEr New Device Study

NCT06271967Not ApplicableCompletedPrimary

FOCALFLEX (CE Mark) Study

NCT07358429Active Not Recruiting

CPAP Therapy and Atrial Fibrillation Recurrence in OSA

NCT07321964Not ApplicableRecruiting

The Effect of a Digital MediYoga Program on Quality of Life, Blood Pressure and Heart Rate Among Patients With Atrial Fibrillation

NCT06754176Not ApplicableRecruiting

Full-Avoidance vs. Permissive/Regulated Drinking & Outcomes On Fibrillation

NCT06392932Not ApplicableRecruitingPrimary

Esophageal Temperature During PVI Using Q-DOT Micro

NCT07175727Not ApplicableCompletedPrimary

TWOSOME Trial: Single-Shot Versus Single-Tip Pulsed Field Ablation for Pulmonary Vein Isolation

Scroll to load more

Research Network

Activity Timeline